Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2020-001237
Abstract: Background South America has a higher incidence of gestational trophoblastic disease than North America or Europe, but whether this impacts chemotherapy outcomes is unclear. The purpose of this study was to evaluate outcomes among women… read more here.
Keywords: disease centers; risk; risk gtn; high risk ... See more keywords
Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
Sign Up to like & getrecommendations! Published in 2018 at "Medical Journal of the Islamic Republic of Iran"
DOI: 10.14196/mjiri.32.36
Abstract: Background: Gestational trophoblastic neoplasia (GTN) originates from placental trophoblast and is a highly chemosensitive and curable gynecologic malignancy. The present study was conducted to evaluate the effectiveness and safety of EMA/EP (etoposide, methotrexate, actinomycin-D, etoposide,… read more here.
Keywords: risk gtn; high risk; treatment; ema regimen ... See more keywords